REG - Ilika plc - Stereax Battery Milestone at Cirtec Medical

IlikaAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250818:nRSR5908Va&default-theme=true

RNS Number : 5908V  Ilika plc  18 August 2025

18 August 2025

Ilika plc

('Ilika,' the 'Company,' or the 'Group')

 

 Stereax Battery Production Milestone at Cirtec Medical

Ilika and Cirtec Medical Achieve Manufacturing Milestone for Revolutionary
Medical-Grade Micro-Batteries

·    Manufacturing process qualification completed for Ilika's Stereax
micro-batteries at Cirtec Medical's US facility

·    Production commenced for product testing and initial customer
deliveries

·    Partnership advances miniaturisation capabilities for implantable
medical devices

 

Ilika (AIM: IKA), a global pioneer in solid-state battery technology, today
announced a significant manufacturing milestone with strategic partner Cirtec
Medical Corp ("Cirtec Medical"). The companies have successfully completed
process qualification for the Stereax M300 micro-battery production line at
Cirtec Medical's facility in Lowell, Massachusetts.

This achievement follows January 2025's successful equipment commissioning and
represents the final technical validation before commencement of production.
The qualified manufacturing line includes sophisticated layer deposition,
alignment, and patterning systems essential for producing medical-grade
micro-batteries.

The milestone activates a ten-year manufacturing agreement signed in August
2023, under which Cirtec Medical will produce Ilika's Stereax battery
portfolio. This collaboration combines Ilika's advanced battery technology
with Cirtec Medical's established medical device manufacturing expertise to
address growing demand for miniaturised medical implants.

Initial deliveries of Stereax M300 batteries to lead customers are targeted to
commence in 2025.

Graeme Purdy, Ilika Chief Executive Officer, said: "This manufacturing
milestone demonstrates the successful technology transfer of our proprietary
Stereax platform to commercial production scale. The strong customer interest
we're seeing validates the market need for miniaturised solid-state batteries
in medical devices. With the combination of Ilika's expertise and Cirtec
Medical's world-class manufacturing capabilities, we are well-positioned to
meet growing customer demand in 2025 and beyond."

Ed Philbin, Cirtec Medical Interim Chief Executive Officer, said: "The
successful qualification of Stereax battery production strengthens our
position as a leading manufacturer of next-generation medical devices. By
incorporating Ilika's innovative micro-battery technology into our vertically
integrated manufacturing capabilities, we can offer our customers
unprecedented opportunities for device miniaturisation and enhanced
performance in implantable medical applications."

-      ENDS -

 

 

Enquiries:

 

 Ilika Plc                                             www.ilika.com (http://www.ilika.com/)
 Graeme Purdy, Chief Executive

                                                     Via FTI Consulting
 Jason Stewart, Chief Financial Officer

 Cavendish Capital Markets Limited (Nomad and Broker)  +44 (0)131 220 9772
 Peter Lynch

                                                     +44 (0)131 220 9771
 Neil McDonald

 FTI Consulting (Comms Advisors)                       ilika@fticonsulting.com (mailto:ilika@fticonsulting.com)

 Ben Brewerton

 Elizabeth Adams

 Dwight Burden

 

About Ilika Technologies

Ilika is a global expert in the development of solid-state battery technology
for electric vehicles, medical devices and consumer appliances. The Company's
pioneering next-generation technologies aim to provide scalable, affordable
alternatives to conventional batteries, to industries which need to
incorporate a smaller, lighter, and safer power source in their products.

The Company has two product lines. Its Stereax batteries are designed for
powering miniature medical im-plants, industrial wireless sensors and Internet
of Things (IoT) applications and the Goliath large format batteries designed
for EV cars and cordless appliances.

Through its licensing business model, Ilika supplies its IP portfolio to both
OEMs and manufacturing partners in exchange for a license fee and future
royalties.

About Cirtec Medical

Cirtec Medical is a global leader in outsourced design, development, and
manufacturing of complex Class II and III medical devices, specializing in
active implant systems, interventional devices and precision components. Since
1987, Cirtec has built extensive in-house capabilities that enable it to serve
as a single-source partner and collaborate with its customers to transform
their technology into innovative medical devices across a wide array of
therapies, including cardiology, neurology, orthopedics and other minimally
invasive device applications.

Cirtec Medical's deep expertise in precision component design and
manufacturing can support every stage of the product lifecycle, ensuring
uncompromising quality and performance. With 11 global facilities and a
vertically integrated approach, Cirtec Medical aims to expedite time to
market, reduce risk, and accelerate revenue generation for our partners.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPKPBBQBKDPFD